<!DOCTYPE html>
<html lang="en">
  
<!-- Mirrored from www.allindianpatents.com/patents/256184-method-of-producing-optically-active-alcohol by HTTrack Website Copier/3.x [XR&CO'2014], Fri, 05 Apr 2024 09:49:57 GMT -->
<!-- Added by HTTrack --><meta http-equiv="content-type" content="text/html;charset=utf-8" /><!-- /Added by HTTrack -->
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=Edge,chrome=1">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Indian Patents. 256184:METHOD OF PRODUCING OPTICALLY ACTIVE ALCOHOL</title>
    <meta content="authenticity_token" name="csrf-param" />
<meta content="cYcP52B8zyTWKbLwby2YPh9z/gvY/RLjWOwY4YXkiXg=" name="csrf-token" />

    <!-- Le HTML5 shim, for IE6-8 support of HTML elements -->
    <!--[if lt IE 9]>
      <script src="//cdnjs.cloudflare.com/ajax/libs/html5shiv/3.6.1/html5shiv.js" type="text/javascript"></script>
    <![endif]-->

    <link href="../assets/application-e80cf34975c5b1730c80b2f7170e7d26.css" media="all" rel="stylesheet" type="text/css" />

  </head>
  <body>

    <div class="navbar navbar-fluid-top">
      <div class="navbar-inner">
        <div class="container-fluid">
          <a class="btn btn-navbar" data-target=".nav-collapse" data-toggle="collapse">
            <span class="icon-bar"></span>
            <span class="icon-bar"></span>
            <span class="icon-bar"></span>
          </a>
          <a class="brand" href="../index.html">Indian Patents</a>
          <div class="container-fluid nav-collapse">
            <ul class="nav">
              <li><a href="../recently-granted.html">Recently Granted Patents</a></li>
              <li><a href="../recently-published.html">Recently Published Patents</a></li>
            </ul>
            <form id="gform" class="navbar-search pull-right" action="https://www.google.com/search" method="get" target="_blank" onsubmit="document.getElementById('gform').q.value='site:http://www.allindianpatents.com '+document.getElementById('gform').q.value">
                <input type="text" name="q" id="q" class="search-query" placeholder="Search" onclick="this.value=''" autocomplete="off">
            </form>
          </div><!--/.nav-collapse -->
        </div>
      </div>
    </div>

    <div class="container-fluid">
      <div class="row-fluid">
        <div class="span12">

          <style>
          .allindianpatents-top { width: 320px; height: 50px; }
          @media(min-width: 500px) { .allindianpatents-top { width: 468px; height: 60px; } }
          @media(min-width: 800px) { .allindianpatents-top { width: 728px; height: 90px; } }
          </style>
          <center>
          </center>
          
          <div class="row-fluid">
	<div class="span8">

		<table class="table">
			<tr>
				<th>Title of Invention</th>
				<td><h1 style="font-size:large;">METHOD OF PRODUCING OPTICALLY ACTIVE ALCOHOL</h1></td>
			</tr>
			<tr>
				<th>Abstract</th>
				<td>This invention relates to a process for preparing an optically active alcohol represented by formula (V): wherein, R1 and R2 are as described in the specification, which comprises: reducing aromatic ketones represented by formula (I): wherein R1 and R2 are as described in the specification, with sodium borohydride, chlorotrimethylsilane and optically active 2-[bis(4-methoxyphenyl)hydroxymethyl]pyrrolidine represented by formula (IV): to give optically active alcohol represented by formula (V).</td>
			</tr>
		</table>

					<style>
					.allindianpatents-post-abstract { width: 320px; height: 50px; }
					@media(min-width: 880px) { .allindianpatents-post-abstract { width: 468px; height: 60px; } }
					@media(min-width: 1267px) { .allindianpatents-post-abstract { width: 728px; height: 90px; } }
					</style>
					<center>
					<script async src="https://pagead2.googlesyndication.com/pagead/js/adsbygoogle.js"></script>
					<!-- AllIndianPatents-post-abstract -->
					<ins class="adsbygoogle allindianpatents-post-abstract"
					     style="display:inline-block"
					     data-ad-client="ca-pub-7914358224572760"
					     data-ad-slot="9152759240"></ins>
					<script>
					(adsbygoogle = window.adsbygoogle || []).push({});
					</script>					
					</center>

		<table class="table">
			<tr>
				<th>Full Text</th>
				<td> <br><br>
TECHNICAL FIELD<br>
This invention relates to a process for producing optically active alcohols using asymmetric reduction of<br>
aromatic ketones.<br>
BACKGROUND TECHNOLOGY<br>
Hydroxyalkyl	substituted	azetidinone	derivatives,	such	as	ezetimibe<br>
([l-(4-fluorophenyl)-(3R)-[3-(4-fluorophenyl)-(3S)-hydroxypropyl]-(4S)-(4-hydroxyphenyl)azetidin-2-one])<br>
represented by formula XII, are useful as hypochlesterolemic agents in the prevention and treatment of<br>
atherosclerosis.<br><br>
Several processes have been reported for the preparation of diphenylazetidinones. (Journal of Organic Chemistry,<br>
1999, 64, 3714, Journal of Medicinal Chemistry, 1998,41 973, U.S Patent No. 5,631,365; 5,886,171; 6,207,822;<br>
6,133,001; 5,856,473, WO2005/066120, JP 2002-531546, JP 2005-53931) .<br>
These	processes	involve	that	the	β-lactam	ring	construction	using<br>
3-[(5S)-(4-fluorophenyl)-5-hydroxypentanoyl]-(4S)-phenyl-l ,3-oxazolidin-2-one (VII) (method 1) or asymmetric<br>
reduction of derivatives having carbonyl group in side chain at 3-position of β-lactam ring such as<br>
(4S)-(benzyloxyphenyl)-1-(4-fluorophenyl)-(3R)-[3-(4-fluorophenyl)-3-<br>
oxopropyl]azetidin-2-one (X) (method 2).<br>
In Method 1,	the intermediate, the hydroxyl group of 3-[(5S)-(4- fluorophenyl)-5-<br>
hydroxypentanoyl]-(4S)-phenyl-l ,3-oxazolidin-2-one (VII) is protected with a suitable protecting group such as<br>
trimethylsilyl group or t-butyldimethylsilyl group, was used (U.S Patent No. 6,207,822, WO2005/066120, JP<br>
2002-531546, JP2005-53931) . 3-[(5S)-(4- fluorophenyl)-5- hydroxypentanoyl]-(4S)-phenyl-l,3-oxazolidin-2-one<br>
(VII) is synthesized by stereoselective microbial reduction of 3-[5-(4- fluorophenyl)-5-oxopentanoyl]-<br>
(4S)-phenyl-l,3-oxazolidin-2-one (VI) (U.S.Patent No. 5,618,707).<br>
It is reported mat 3-[(5S)-(4- fluorophenyl)-5- hydroxypentanoyl] -(4S)-<br>
phenyl-l,3-oxazolidin-2-one (VII) is synthesized by asymmetric reduction of<br>
3-[5-(4-fluorophenyl)-5-oxopentanoyl]-(4S)-phenyl-l,3-oxazolidin-2-one (VI) ( U.S Patent No. 6,207,822;<br>
6,627,757, Tetrahedron Letters, 2003, 44, 801.) . These processes are reduction by borane-dimethylsulfide<br>
complex	or	borane-tetrahydrofuran	complex	using<br>
(R)-tetraydro)-1-methyl-3,3-diphenyl-1H,3H-pyrrolo(l,2-c)(l,2,3)-oxazaborolidine [(R)-MeCBS; XIII] as a<br>
catalyst to afford the corresponding alcohol in high enantioselectivity.<br><br><br>
However, the enatioselectivity of the reduction depends on rate and mode of addition of borane-complex, moisture<br>
sensitivity of the reaction medium and the reaction temperature. Moreover, the reduction using a chiral catalyst<br>
leads to problems associated with the formation of over reduced products, such as compound (XIV) (Tetrahedron<br>
Letters, 2003,44,801).<br><br>
Borane-dimethylsulfide complex and borane-tetrahydrofuran-complex are expensive and toxic.<br>
Furthermore, the handling of these reagents is not easy at large production due to borane is gas.<br>
(R)-MeCBS (XIII) is commercially available, but it is expensive. Moreover, the recycle process is<br>
required, since (R)-2-(diphenylhydroxymethyl)pyrrolidine (XV), the product that (R)-MeCBS '<br>
(XIII) is decomposed by workup operations, is recovered. In this case, it is necessary expensive<br>
boron carrier such as trimethylboroxine to prepared (R)-MeCBS (XIII) .<br><br>
WO2005/066120 discloses the synthetic methods of 3-[(5S)-(4-fluorophenyl)- 5-<br>
hydroxypentanoyl]-(4S)-phenyl-l,3-oxazolidin-2-one (VII) and (5S)-(4-fluorophenyl)-5-<br>
hydroxypentanoic acid methyl ester (IX) using (-)-B-chlorodiisopinocampheylborane (XVI) as a reducing agent.<br><br>
(5S)-5-(4-fluorophenyl)-5- hydroxypentanoic acid methyl ester (IX) is converted to 3-[(5S)- (4-<br>
fluorophenyl)-5- hydroxypentanoyl]-(4S)- phenyl -l,3-oxazolidin-2-one (VII) in this patent This reaction also<br>
shows high selectivity, however a stoichiometric amount of reducing agent is necessary.<br>
In method 2 , (4S)-(4-benzyloxyphenyl)-l -(4-fluorophenyl)-(3R)-[(3S)-(4-fluorophenyl)- 3-<br>
hydroxypropyl]azetidin-2-one (XI) is produced in high stereoselectivity by borane-complex asymmetric reduction<br>
of (4S)-(4-benzyloxyphenyl)-l -(4-fluorophenyl)-(3R)-[3-(4- fluorophenyl)-<br>
3-oxopropyl]azetidin-2-one (X) using (R&gt;MeCBS (XIII) as a catalyst Compound (XI) is converted<br>
to ezetimibe (XII) by the removal of benzyl group (Journal of Organic Chemistry, 1999,64.3714) .<br>
However, this process is also used expensive (R)-MeCBS (XIII) and borane-complex.<br>
It is reported the asymmetric reduction of aromatic ketones by sodium borohydride, chlorotrimethylsilane and a<br><br>
catalytic amount of optically active 2-(diphenylhydroxymethyl)pylrolidine (XV) system (Tetrahedron Letters,<br>
2000, 41. 10281). This reaction doesn't require low reaction temperature. Furthermore, cheep and low toxic<br>
reagents are used in this reduction system. Moreover, 2-(diphenylhydroxymethyl)pyrroIidine (XV) is easily<br>
recovered at workup operations in high yleld, and recyclable after purification such as recrystallization.<br>
Reduction of 3-[5-(4- fluorophenyl)-5-oxopentanoyl]-(4S)-phenyl-l ,3-oxazolidin-<br>
2-one (VI) by this system gives 3-[(5S)-(4- fluorophenyl)-5-hydroxypentanoyl]-(4S)-phenyl-<br>
l,3-oxazolidin-2-one (VIII ) in high yleld and enantioselectivity [ 1 g scale<br>
((R)-2-(diphenylhydroxymethyl)pyrrolidine 10 mol%) : de 87%) . However, Tendency of the decreased<br>
enantioselectivity of the product is observed at scale-up production [ 10 g scale<br>
((R)-2-(diphenylhydroxymethyl)pyrrolidine 10 mol%) : de 74%) . Accordingly, the development of catalyst,<br>
which shows high enantioselectivity at large scale production, is desired.<br>
DISCLOSURE OF INVENTION<br>
This invention provides the synthetic method that shows high enantioselectivity at large scale production of<br>
optically active alcohols by asymmetric reduction of aromatic ketones. In the course of study on the development<br>
of a enantioselective method of preparing optically active alcohols, inventors found that use of optically active<br>
2-[bis(4-methoxyphenyl)hydroxymethyl]pyrrolidine	(IV)	instead	of	optically	active<br>
2-(diphenylhydroxymethyl)pyrrolidine provides the alcohols in high enantioselectivity at large scale production.<br>
This invention relates to a process for producing optically active alcohols.<br>
Namely, this invention provides process that aromatic ketones represented by formula (I)<br><br>
[wherein, R1 are selected from hydrogen atom, halogen atom, lower alkyl group (1 to 5 carbon atom) , lower<br>
haloalkyl group (1 to 5 carbon atom) , lower alkoxycarbonyl group (1 to 5 carbon atom) , lower alkoxy group<br>
(1 to 5 carbon atom) , hydroxyl group, nitro group, cyano group, lower acyloxy group (1 to 5 carbon atom) ,<br>
lower alkylthio group (1 to 5 carbon atom) , lower alkylsulfonyl group (1 to 5 carbon atom) , substituted and<br>
unsubstituted amino group, substituted and unsubstituted carbamoyl group, substituted and unsubstituted aromatic<br>
ring or heteroaromatic ring. R2 is -(CH2)n-R3 [wherein n is 1 to 5 integer. R3are selected from hydrogen atom,<br>
halogen atom, lower alkoxycarbonyl group (1 to 5 carbon atom), lower alkoxy group (1 to 5 carbon atom), lower<br>
alkylthio group (1 to 5 carbon atom) , lower alkylsulfonyl group (1 to 5 carbon atom) , substituted and<br>
unsubstituted amino group, unsubstituted carbamoyl group, substituted and unsubstituted aromatic ring or<br>
heteroaromatic ring and formula (II) :<br><br>
{wherein, R4 are selected from lower alkyl group (1 to 5 carbon atom) , substituted and unsubstituted aromatic<br>
ring, and substituted and unsubstituted benzyl group.}<br><br>
and formula (III) :<br><br>
{wherein, R5 and R6are the same or different and are selected from hydrogen atom, halogen atom, lower alky]<br>
group (1 to 5 carbon atom) , lower haloalkyl group (1 to 5 carbon atom) , lower alkoxycarbonyl group (1 to 5<br>
carbon atom) , lower alkoxy group (1 to 5 carbon atom) , lower acyloxy group (1 to 5 carbon atom) , hydroxyl<br>
group, nitro group, cyano group, substituted and unsubstituted benzyloxy group, substituted silyloxy group, lower<br>
alkylthio group (1 to 5 carbon atom) , lower alkylsulfonyl group (1 to 5 carbon atom) , substituted and<br>
unsubstituted amino group, substituted and unsubstituted carbamoyl group, substituted and unsubstituted aromatic<br>
ring or heteraromatic ring, substituted and unsubstituted tetrahydropyranyl group, lower alkyl group containing<br>
substituted and unsubstituted tetrahydropyranyl group (1 to 5 carbon atom) , lower alkyl group containing amino<br>
group (1 to 5 carbon atom) }) ] are reduced by sodium borohydride, chlorotrimethylsilane and optically active<br>
(R)-2-[b is(4-memoxyphenyl)hydroxymethyl]pyrrelidine represented by formula (IV)	<br><br>
to give optically active alcohol represented by formula (V) stereoselectively. <br><br>
(wherein, R1 and R2 are as defined above.)<br>
This invention also provides process that 3-[5-(4-fluorophenyl)-5-oxopentanoyl]-(4S)- phenyl-<br>
1,3-oxazolidin-2-one represented by formula (VI)<br><br>
is reduced by sodium borohydride, chlorotrimethylsilane and optically active<br>
(R)-2-[bis(4-methoxyphenyl)hydroxymethyl]pyrrolidine represented by formula (IV)<br><br>
to give 3-[(5S)-(4-fluorophenyl)-5-hydroxypentanoyl]-(4S)-phenyl-1,3-oxazolidin-2-one represented by formula<br>
(VII) stereoselectively.<br><br><br>
This invention also provides process that 5-(4-fluoropheny1)-5-oxopentanoic acid methyl ester represented by<br>
formula (VIII)<br><br>
is reduced by sodium borohydride, chlorotrimethylsilane and optically active<br>
(R)-2-[bis(4-methoxyphenyl)hydroxymethyl]pyrrolidine represented by formula (IV)<br><br>
to give (5S)-(4-fluorophenyl)-5-oxopentanoic acid methyl ester represented by formula (IX) stereoselectively.<br><br>
This invention also provides process that (4S)-(4-benzyloxyphenyl)-1-(4- fluorophenyl)-(3R)-[3-(4-<br>
fluorophenyl)-3oxopropyl]azetidin-2-one represented by formula (X)<br><br>
is reduced by sodium borohydride, chlorotrimethylsilane and optically active (R)<br>
2-[bis(4-methoxyphenyl)hydroxyme1hyl]pylTolidine represented by formula (IV)<br><br>
to	give	(4S)-(4-benzyloxyphenyl)-l -(4-fluorophenyl)-(3R)-[(3SH4-fluorophenylH3S)-<br>
3-hydoxypropyl]azetidin-2-one represented by formula (XI) stereoselectively.<br><br><br>
BEST MODE FOR CARRYING OUT THE INVENTION<br>
Compounds represented by general formula (I) are defined herein. R1 are selected from hydrogen atom, halogen<br>
atom (e.g. fluorine atom, chlorine atom, bromine atom, iodine atom), alkyl group (e.g. methyl group, ethyl group,<br>
propyl group, butyl group, pentyl group, haloalkyl group (e.g. trifluoromethyl group, 2,2,2,-trifluoroethyl group),<br>
alkoxycarbonyl group (e.g. methylxycarbonyl group, ethoxycarbonyl group, propyloxycarbonyl group,<br>
butoxycarbonyl group, pentyloxycarbonyl group), alkoxy group (e.g. methoxy group, ethoxy group, propyloxy<br>
group, butoxy group, penryloxy group), hydroxyl group, nitro group, cyano group, acyloxy group (e.g. acetyloxy<br>
group, propionyloxy group), alkylthio group (e.g. methylthio group, ethylthio group, propylthio group, butylthio<br>
group, pentylthio group) , alkylsulfonyl group (e.g. methylsulfonyl group, ethylsulfonyl group, propylsulfonyl<br>
group, butylsulfonyl group, pentylsulfonyl group) , substituted or unsubstituted amino group (e.g. amino group,<br>
methylamino group, ethylamino group, propylamino group, butylamino group, pentylamino group,<br>
dimethylamino group, diethylamino group, dipropylamino group, dibutylamino group, dipentylamino group,<br>
acetylamino group, propionylamino group, methoxycarbonylamino group, ethoxycarbonylamino group,<br>
propionylcarbonylamino group, butoxycarbonylamino group, pentyloxycarbonylamino group,<br>
methylsulfonylamino group, ethylsulfonylamino group), substituted or unsubstituted carbamoyl group (e.g.<br>
carbamoyl group, methylaminocarbonyl group, ethylaminocarbonyl group, propylaminocarbonyl group,<br>
butylaminocarbony] group, pentylaminocarbonyl group, dimethylamino group, diethylamino group,<br>
diethylaminocarbonyl group, dipropylaminocarbonyl group, dibutylaminocarbonyl group, dipentylaminocarbonyl<br>
group), substituted or unsubstituted aromatic ring (e.g. phenyl group, fluorophenyl group, chlorophenyl group,<br>
bromophenyl group, iodophenyl group, methylphenyl group, methoxyphenyl group, aminophenyl group,<br>
cyanophenyl group, methylthiophenyl group, methylsulfamoylphenyl group, methylsulfonylphenyl group, naphtyl<br>
group, azulenyl group, biphenyl group, phenoxyphenyl group) or heteroaromatic ring (e.g. pyridine ring, furan<br>
ring, thiophene ring, imidazole ring, thiazole ring, benzofuran ring, benzothiophene ring, benzimidazole ring,<br>
benzothiazole ring) .<br>
R2 are selected from alkyl group (e.g. methyl group, ethyl group, propyl group, butyl group, pentyl group) ,<br>
haloalkyl group (e.g. chloromethyl group, 2-chloroethyl group, 3-chloropropyl group, 4-chlorobutyl group,<br>
5-chloropentyl group, bromomethyl group, 2-bromoethyl group, 3-bromopropyl group, 4-bromobutyl group,<br>
5-bromopentyl group, iodomethyl group, 2-iodoethyl group, 3-iodopropyl group, 4-iodobutyl group, 5-iodopentyl<br>
group ) , alkyl group containing methoxycarbonyl group ( e.g. methoxycarbonylmethyl group,<br>
2-methoxycarbonylethyl group, 3-methoxycarbonylpropyl group, 4-methoxycarbonylbutyl group,<br>
5-methoxycarbonylpentyl group, 3-ethoxycarbonylpropyl group, 3-propyloxycarbonylpropyl group,<br>
3-butoxycarbonylpropyl group, 3-penryloxycarbonylpropyl group) , alkyl group containing alkoxy group (e.g.<br>
methoxymethyl group, 2-methoxyemyl group, 3-methoxypropyl group, 4-methoxybutyl group, 5-methoxypentyl<br>
group, 4-ethoxybutyl group, 4-propyloxybutyl group, 4-butoxybutyl group, 4-pentyloxybutyl group) , hydroxyl<br><br>
group, alkyl group containing alkylthio group (e.g. methylthiomethyl group, 2-methylthioethyl group,<br>
3-methylthiopropyl group, 4-methylthiobutyl group, 5-methylthiopenty group, 4-ethylthiobutyl group,<br>
4-propylthiobutyl group, 4-pentylthiobutyl group) , alkyl group containing alkylsulfonyl group (e.g.<br>
methylsulfonylmethyl group, 2-methylsulfonylethyl group, 3-methylsulfonylpropyl group, 4-methylsulfonylbutyl<br>
group, 5-methylsuIfonylpentyl group, 4-ethylsulfonylbutyl group,	4-propylsulfonylbutyl group,<br>
4-butylsulfonylbutyl group, 4-pentylsulfonylbutyl group) , alkyl group containing substituted or unsubstituted<br>
amino group (e.g. dimethylaminomethyl group, 2-dimethylaminoethyl group, 3-dimethylaminopropyl group,<br>
4-dimethylaminobutyl group,	5-dimethylaminopentyl group,	4-diethylaminobutyl group,<br>
4-dipropylaminobutyl group, 5-dipentylaminobutyl group, acetylaminomethyl group, 2-acetylaminoethyl<br>
group,	3-acetylaminopropyl group,	4-acetylaminobutyl group,	5-acetylaminopentyl group,<br>
4-propionylaminobutyl group, methoxycarbonylaminomethyl group, 2-methoxycarbonylaminoethyl group,<br>
3-methoxycarbonylaminopropyl group, 4-methoxycarbonylaminobutyl group, 5-methoxycarbonylaminopentyl<br>
group,	4-ethoxycarbonylaminobutyl group,	4-propyloxycarbonylaminobutyl group,<br>
4-butoxycarbonylaminobuty group, 4-pentyloxycarbonylaminobutyl group, methylsulfonylaminomethyl group,<br>
2-methylsulfonylaminoethyl group, 3-methylsulfonylaminopropyl group, 4-methylsulfonylaminobutyl group,<br>
S-methylsulfonylaminopentyl group, 4-ethylsulfonylaminobutyl group, 4-propylsulfonylaminobutyl group,<br>
4-butylsulfonylaminobutyl group, 4-pentylsulfonylaminobutyl group, alkyl group containing substituted or<br>
unsubstituted carbamoyl group (e.g. carbamoylmethyl group, 2-carbamoylethyl group, 3-carbamoylpropyl<br>
group, 4-carbamoylbutyl group, 5-carbamoylpentyl group, 3-methylaminocarbonylpropyl group,<br>
3-dimethylaminocarbamoylpropyl group, 3-ethylaminocarbonylpropyl group, 3-diethylaminocarbonylpropyl<br>
group,	3-propylaminocarbonylpropyl group,	3-dipropylaminocarbonylpropyl group,<br>
3-butylaminocarbonylpropyl group, 3-propylaminocarbonylpropyl group, 3-butylaminocarbonylpropyl group,<br>
3-dibutylaminocarbonylpropyl group, 3-pentylaminocarbonylpropyl group, 3-dipentylaminocarbonylpropyl<br>
group) , alkyl group containing substituted or unsubstituted aromatic ring [e.g. benzyl group, 2-phenylethyl group,<br>
3-phenylpropyl group, 4-phenylbutyl group, 5-phenylpentyl group, 4-(fluorophenyl)butyl group,<br>
4-(chlorophenyl)butyl group, 4-{bromophenyl)butyl group, 4-(iodophenyl)butyl group, 4-(methylphenyl)butyl<br>
group, 4-(methoxyphenyl)butyl group, 4-(aminophenyl)butyl group, 4-(cyanophenyl)butyl group,<br>
4-(methylthiphenyl)butyl group, 4-(methylsulfonylphenyl)butyl group, 4-(naphtyl)phenyl, 4-(azulenyl)butyl<br>
group], alkyl group containing substituted or unsubstituted heteroaromatic ring [e.g. 4-(pyridyl)butyl group,<br>
4-(furyl)butyl group, 4-(thiophenyl)butyl group, 4-(imidazolyl)butyl group, 4-(thiazolyl)butyl group,<br>
4-(benzofuryl)butyl group, 4-(benzothiophenyl)butyl group, 4-(benzoimidazolyl ) butyl group,<br>
4-<benzothiazolyl group and formula></benzothiazolyl><br>
and formula (XVIII) .<br><br><br>
R4 are selected from alky] group (e.g. methyl group, ethyl group, propyl group, butyl group, isobutyl group,<br>
t-butyl group, pentyl group) , substituted or unsubstituted aromatic ring (e.g. phenyl group, fluorophenyl group,<br>
chlorophenyl group, bromophenyl group, iodophenyl group, methylphenyl group, methoxyphenyl group,<br>
aminophenyl group, cyanophenyl group, methylthiophenyl group, methylsulfonylphenyl group, naphtyl group,<br>
azulenyl group, biphenyl group, phenoxyphenyl group) x substituted or unsubstituted benzyl group (e.g. benzyl<br>
group, fluorobenzyl group, chlorobenzyl group, bromobenzyl group, iodobenzyl group, methylbenzyl group,<br>
methoxybenzyl group, aminobenzyl group, cyanobenzyl group, methylthiobenzyl group, methylsulfonylbenzyl<br>
group, naphtylmethyl group, azulenylmethyl group, biphenylmethyl group, phenoxybenzyl group) .<br>
R5 and R6are the same or different and are selected from hydrogen atom, halogen atom (e.g. fluorine atom,<br>
chlorine atom, bromine atom, iodine atom) , alkyl group (e.g. methyl group, ethyl group, propyl group, butyl<br>
group, pentyl group, haloalkyl group (e.g. trifluoromethyl group, 2,2,2,-trifluoroethyl group, chloromethyl group,<br>
bromomethyl group, iodomethyl group, 2-bromoethyl group, 3-bromopropyl group, 4-bromobutyl group,<br>
5-bromopentyl group,), lower alkoxycarbonyl group (e.g. methylxycarbonyl group, ethoxycarbonyl group,<br>
propyloxycarbonyl group, butoxycarbonyl group, pentyloxycarbonyl group), lower alkoxy group (e.g. methoxy<br>
group, ethoxy group, propyloxy group, butoxy group, pentyloxy group), lower acyloxy group (acetyloxy group,<br>
propionyloxy group), hydroxyl group, nitro group, cyano group, substituted or unsubstituted benzyloxy group (e.g.<br>
benzyloxy group, fluorobenzyloxy group, chlorobenzyloxy group, bromobenzyloxy group, iodobenzyloxy group,<br>
methylbenzyloxy group, methoxybenzyloxy group, aminobenzyloxy group, cyanobenzyloxy group,<br>
methylthiobenzyloxy group, methylsulfonylbenzyloxy group, naphtylmethyloxy group, azulenylmethyloxy group,<br>
biphenylmethyloxy group, phenoxybenzyloxy group) , substituted silyl group (e.g. trimethylsilyl group,<br>
triethylsilyl group, triisopropylsilyl group, t-butyldimethylsilyl group, t-butyldiphenylsilyl group), alkylthio group<br>
(e.g. methylthio group, ethylthio group, propylthio group, butylthio group, pentylthio group) , alkylsulfonyl<br>
group (e.g. methylsulfonyl group, ethylsulfonyl group, propylsulfonyl group, butylsulfonyl group, penrylsulfonyl<br>
group) ,<br>
substituted or unsubstituted amino group (e.g. amino group, methylamino group, ethylamino group, propylamine*<br>
group, butylamino group, pentylamino group, dimethylamino group, diethylamino group, dipropylamino group,<br>
dibutylamino group, dipentylamino group, acetylamino group, propionylamino group, methoxycarbonylamino<br>
group, ethoxycarbonylamino group, propionylcarbonylamino group, butoxycarbonylamino group,<br>
pentyloxycarbonylamino group, methylsulfonylamino group, ethylsulfonylamino group), substituted or<br>
unsubstituted carbamoyl group (e.g. carbamoyl group, methylaminocarbonyl group, ethylaminocarbonyl group,<br>
propylaminocarbonyl group, butylaminocarbonyl group, pentylaminocarbonyl group, dimethylamino group,<br>
diethylamino group, diethylarriinocarbonyl group, dipropylaminocarbonyl group, dibutylaminocarbonyl group,<br>
dipentylaminocarbonyl group), substituted or unsubstituted aromatic ring (e.g. phenyl group, fluorophenyl group,<br>
chlorophenyl group, bromophenyl group, iodophenyl group, methylphenyl group, methoxyphenyl group,<br>
aminophenyl group, cyanophenyl group, methylthiophenyl group, methylsulfamoylphenyl group,<br><br>
methylsulfonylphenyl group, naphtyl group, azulenyl group, biphenyl group, phenoxyphenyl group) or<br>
heteroaromatic ring (e.g. pyridine ring, furan ring, thiophene ring, imidazole ring, thiazole ring, benzofuran ring,<br>
benzothiophene ring, benzimidazole ring, benzothiazole ring) , substituted or unsubstituted tetrahydropyranyl<br>
group ( e.g. tetrahydropyranyl group, fluorotetrahydropyranyl group, chloro tetrahydropyranyl group,<br>
methyltetrahydropyranyl group, methoxytetrahydropyranyl group, hydroxy tetrahydropyranyl group,<br>
acetoxytetrahydropyranyl group, benzyloxytetrahydropyranyl group, trimethylsilyloxytetrahydropyranyl group,<br>
methoxycarbonyltetrahydropyranyl group, alkyl group containing substituted or unsubstituted tetrahydropyranyl<br>
group [tetrahydropyranylmethyl group, 2-tetrahydropyranylethyl group, 3-tetrahydropyranylpropyl group,<br>
4-tetrahydropyranylbutyl group, 5-tetrahydropyranylpenryl group, 2-{fluorotetrahydropyranyl)ethyl group,<br>
2-(chlorotetrahydropyranyl)ethyl	group,	2-(methyltetrahydropyranyl)ethyl	group,<br>
2-(methoxytetrahydropyranyl)ethyl	group,	2-(hydroxytetrahydropyranyl)ethyl	group,<br>
2-(acetoxytetrahydropyranyl)ethyl	group,	2-(benzyloxytetrahydropyranyl)ethyl	group,<br>
2-(trimethylsilyloxytetrahydropyranyl)ethyl group, 2-(methoxycarbonyltetrahydropyranyl)ethyl group], alkyl<br>
group containing amino group ( e.g. dimethylaminomethyl group, 2-dimethylaminoethyl group,<br>
3-dimethylaminopropyl group, 4-dimethylaminobutyl group, 5-dimethylaminopentyl group, 4-diethylaminobutyl<br>
group, 4-dipropylaminobutyl group, 5-dipentylaminopentyl group) .<br>
This invention is a process for producing optically active alcohols by asymmetric reduction of aromatic ketones<br>
represented by general formula (I) using sodium borohydride, chlorotrimethylsilane and optically active<br>
2-[bis(4-methoxyphenyl)hydroxymethyl]pyrrolidine (IV) .<br>
Optically active 2-[bis(4-methoxyphenyl)hydroxymethyl]pyrrolidine (IV) , which is used in this invention, can be<br>
synthesized from D- or L-proline according to the literatures (Journal of Chemical Society, Perkin Trans 1,1985,<br>
2039; Journal of American Society, 1987,109,5551; Tetrahedron, 1993,42,5127; Synthesis, 2004,217) .<br>
The reaction is carried out in one-pot according to the method described in Tetrahedron Letters (2000, 41,<br>
10281). This reaction is consisted with 3 steps operations.<br>
1	step : The reaction of sodium borohyderide with chlorotrimethylsilane.<br>
2	step : Preparation of asymmetric reducing agent by the addition of optically active<br>
2-[bis(4-methoxyphenyl)hydroxymethyl]pyrrolidine into 1 step reaction mixture.<br>
3	step : Aromatic ketone is reduced by the addition into 2 step reaction mixture to give optically active alcohol.<br>
1	step : The amount of sodium borohyderide and chlorotrimethylsilene is 1 to 1.5-fold mol per aromatic ketone.<br>
Preferably amount is 1.2 to 1.4-fold mol. The reaction is carried out in inert solvent such as ethereal<br>
solvent (ether, isopropyl ether, t-butyl methyl ether, tetrahydrofuran, 1,4-dioxane) and halogenated<br>
solvent (dichloromethane, 1,2-dichloroethane). Preferably reaction solvent is tetrahydrofuran. The<br>
reaction is carried out under reflux temperature and reaction time is about 1 hr.<br>
2	step : The mixture of sodium borohydride and chlorotrimethylsilane is reacted with<br>
2-[bis(4-methoxyphenyl)hydroxymethyl]pyrrolidine by the dropwise addition. The reaction is carried<br>
out at 01 to 40 *C and reaction time is 0.5 hr. The amount of optically active<br>
2-[bis(4-methoxyphenyl)hydroxymethyl]pyrrolidine is 5 mol% to 20 mol% per aromatic ketone.<br>
Preferably amount is 10 mol%.<br>
3	step : Aromatic ketone is reduced by asymmetric reducing agent prepared in 1 step and 2 step. Aromatic ketone<br>
is added dropwise to reaction mixture. The reduction is carried out at 0oC to 40oC. Preferably reaction<br><br>
temperature is 15oC to 30oC.<br>
3-[5-(4-Fluorophenyl)-5-oxopentanoyl]-(4S)-phenyl-1,3-oxazolidin-2-one	(	VI	)	and<br>
5-(4-fluorophenyl)-5-oxopentanoic acid methyl ester (VIII) can be prepared in accordance with procedure in US<br>
Patent No. 6,207,822.<br>
(4S)-(4-Benzyloxyphenyl)-l -(4-fluoropheny])-(3R)-[3-{4-fluorophenyl)-3-oxopropyl]azetidin-2-one (X) can<br>
be synthesized as described in Journal of Organic Chemistry, 1999, 64, 3714 or Journal of Medicinal Chemistry,<br>
1998,41, 973.<br>
3-[(5S)-(4-Fluorophenyl)-5-hydroxypentanoyl]-(4S)-phenyl-1,3-oxazolidin-2-one (VII) , which is<br>
obtained by the asymmetric reduction of 3-[5-(4-fluorophenyl)-5-oxopentanoyl]-(4S)-phenyl-<br>
1,3-oxazolidin-2-one (VI) , is available to produce ezetimibe by the β-lactam ring construction.<br>
On the other hand, (5S)-(4-fluorophenyl)-5-hydroxypentanoic acid methyl ester (IX), which is obtained by the<br>
asymmetric reduction of 5-(4-fluorophenyl&gt;5-oxopentanoic acid methyl ester (VIll) , is utilized to produce<br>
3-[(5S)-(4-fluorophenyl)-5-hydroxypentanoyl]-(4S)-phenyl-1,3-<br>
oxazolidin-2-one (VII) . Furthermore, (4S)-(4-benzyloxyphenyl)-1-{4-fluorophenyl)-(3R)- [(3S)-<br>
(4-fluorophenyl)-3-hydroxypropyl]azetidin-2-one (XI) , which is obtained by the asymmetric reduction of<br>
(4S)-(4-benzyloxyphenyl)-1-(4-fluorophenyl)-(3R)-[3-(4-fluorophenyl)-3-<br>
oxopropyl]azetidin-2-one (X), is available to produce ezetimibe.<br>
[Example 1]<br>
Preparation-[(5S)-4-fluorophenyl)-5-hydroxypentanoyl]-(4S)-phenyl-1,3-oxazolidin-2-one<br>
Chlorotrimethylsilane (25.0 mL, 0.197 mol) was added to a suspension of sodium borohydride (7.45 g, 0.197 mol)<br>
in tetrahydrofuran (700.0 mL) at 24oC, and the reaction mixture was stirred under reflux for 1 hr. The reaction<br>
mixture was cooled to 24oC, and a solution of (R)-2-<br>
[bis(4-methoxyphenyl)hydroxymethyl]pyrrolidine (4.41 g, 0.014 mol) in tetrahydrofuran (280.0 mL) was added.<br>
After stirring for 0.5 hr, a solution of 3-[5-(4-fluorophenyl)-5-oxopentanoyl]- (4S)-<br>
phenyl-1,3-oxazolidin-2-one (50.00 g, 0.141 mol) in tetrahydrofuran (280.0 mL) was added dropwise during 80<br>
min. After stirring for 10 min, the reaction mixture was cooled to A°C. 6N-HC1 was added to the reaction mixture,<br>
and water and toluene were added. After stirring for 30 min, the organic layer was separated. The organic layer<br>
was washed with water, aqueous saturated sodium bicarbonate and aqueous saturated sodium chloride, and dried<br>
over	sodium	sulfate.	Filtration	and	evaporation	gave<br>
3-[(5S)-(4-fluorophenyl)-5-hydroxypentanoyl]-(4S)-phenyl-1,3-oxazolidin-2-one 48.71 g as colorless oil.<br>
1H-NMR(CDC13)δ= 1.56-1.75 (m, 4H), 1.97 (d, J=3Hz, 1H), 2.96-2.99 (m, 2H), 4.28 (dd, J=3Hz, 9Hz, 1H),<br>
4.56-4.66 (m, 1H), 4.68 (t, J=9Hz, 1H), 5.40 (dd, J=3Hz, 9 Hz, 1H), 6.98-7.02 (m, 2H), 7.25-7.37 (m, 7H).<br>
The de [diastereoselectivty de (%)=[(S,S)%-(R,R)%]] of the desired product was determined to be 93% by HPLC<br>
using a chiral column, [column: CHIRALCELL OD-H (DAICEL),mobile phase : ethanol/n-hexane= 1/5 (v/v)^<br>
detection : UV at 258 nm].<br>
[Example 2]<br>
The loading amount (mol%) of (R)-2-[bis(4-methoxyphenyl)hydroxymethyl]pyrrolidine and the reaction scale of<br>
3-[5-(4-fluorophenyl)-5-oxopentanoyl]-(4S)-phenyl-1,3-oxazolidin-2-one (VI) were changed as shown in Table 1,<br>
and 3-[(5S)-4-fluorophenyl)-5-hydroxypentanoyl]-(4S)- phenyl-1,3-<br><br>
oxazolidin-2-one was synthesized using general procedure of Example 1 above. The de (%) of the desired product<br>
was determined by HPLC using a chiral column. The results are summarized in Table 1.<br>
In the reduction of using 3-[5-(4-fluorophenyl)-5-oxopentanoyl]-(4S)-phenyl-l ,3-oxazolidin-2-one as a catalyst,<br>
(R)-2-[bis(4-methoxyphenyl)hydroxymethyl]pyrrolidine	was	replaced	with	(R)-2-<br>
(diphenylhydroxymethyl)pyrrolidine in order to compare the de of the resulting product. As shown in Table 1, the<br>
loading amount (mol%) of (R)-2-(diphenylhydroxymethyl)pyrrolidine and the reaction scale of<br>
3-[5-{4-fluorophenyl)-5-oxopentanoyl]-(4S)-phenyl-1,3-oxazolidin-2-one (VI) were changed. The de (%) of the<br>
desired product was determined by HPLC using a chiral column. The results are summarized in Table 1.<br>
In the reduction of using 3-[5-(4-fluorophenyl)-5-oxopentanoyl]-(4S)-phenyl-1,3-oxazolidin-2-one as a catalyst,<br>
(R)-2-[bis(4-methoxyphenyl)hydroxymethyl]pyrrolidine	was	replaced	with	(R)-2-<br>
[bis(4-trifluorophenyl)hydroxymethyl]pyrrolidine in order to compare the de of the resulting product The loading<br>
amount (mol%) of (R)-2-(diphenylhydroxymethyl)pylTolidine and the reaction scale of<br>
3-[5-(4-fluorophenyl)-5-oxopentanoyl]-(4S)-phenyl-1,3-oxazolidin-2-one (VI) were shown in Table 1. The de (%)<br>
of the desired product was determined by HPLC using a chiral column. The results are summarized in Table 1.<br><br>
As shown in Table 1, when (R)-2-[bis(4-methoxyphenyl)hydroxymethyl]pyrrolidine is used as a catalyst at large<br>
scale production, the de of reaction product increased. In the case of usual (R)-2-<br>
(diphenylhydroxymethyl)pyrrolidine, the de of reaction product decreased at large scale production. When (R)-2-<br>
[bis(4-trifluorophenyl)hydroxymethyl]pyrrolidine was used as a catalyst, the de of reaction product dramatically<br>
decreased at small scale production.<br>
[Example 3]<br>
Preparation of (5S)-(4-fluorophenyl)-5-hydroxypentanoic acid methyl ester<br>
Chlorotrimethylsilane (2.0 mL, 0.01606 mol) was added to a suspension of sodium borohydride (0.61 g, 0.01606<br>
mol) in tetrahydrofuran (63.0 mL) at 20oC, and the reaction mixture was stirred under reflux for 1 hr. The reaction<br>
mixture was cooled to 24oC, and a solution of (R)-2-<br>
[bis(4-methoxyphenyl)hydroxyme1hyl]pyrrolidine (0.42 g, 0.00134 mol) in tetrahydrofuran (10.0 mL) was added.<br><br>
After stirring for 0.5 hr, a solution of 5-(4-fluorophenyl)-5-oxopentanoic acid methyl ester (VIII) (3.00 g, 0.01338<br>
mol) in tetrahydrofuran (10.0 mL) was added dropwise during 45 min. After stirring for 1.5 hr, the reaction<br>
mixture was cooled to 2oC. 6N-HC1 was added dropwise to the reaction mixture, and water and ethyl acetate were<br>
added. After stirring for 30 min, the organic layer was separated. The organic layer was washed with water,<br>
aqueous saturated sodium bicarbonate and aqueous saturated sodium chloride, and dried over sodium sulfate.<br>
Filtration and evaporation gave the crude product, which was purified by silica gel column chromatography (ethyl<br>
acetate/n-hexane) to give (5S)-(4-fluorophenyl)-5-hydroxypentanoic acid methyl ester 2.79 g as colorless oil.<br>
1H-NMR(CDC13)δ= 1.59-1.80 (m, 4H), 2.21 (s, 1H), 2.32-2.36 (m, 2H), 3:65 (s, 3H), 4.63-4.68 (m, 1H),<br>
7.00-7.04 (m, 2H), 7.26-7.32 (m, 2H).<br>
The ee [enantioselectivty ee (%)=[(S)%-(R)%]] of the desired product was determined by HPLC using a chiral<br>
column, [column : CHIRALPAK AD (DAICEL), mobile phase : ethanol/n-hexane= 1/20 (v/v), detection : UV<br>
at 258 nmj. The result is shown in Table 2.<br>
[Comparative Example 1]<br>
Chlorotrimethylsilane (0.86 mL, 0.005352 mol) was added to a suspension of sodium borohydride (0.202 g,<br>
0.005352 mol) in tetrahydrofuran (21.0 mL) at 21oC, and the reaction mixture was stirred under reflux for 1 hr.<br>
The reaction mixture was cooled to 24oC, and a solution of (R)-2-<br>
(diphenylhydroxymethyl)pyrrolidine (0.114 g, 0.0004466 mol) in tetrahydrofuran (5.0 mL) was added. After<br>
stirring for 0.5 hr, a solution of 5-(4-fluorophenyl)-5-oxopentanoic acid methyl ester (VIII) (1.00 g, 0.00446 mol)<br>
in tetrahydrofuran (5.0 mL) was added dropwise during 48 min. After stirring for 0.5 hr, the reaction mixture was<br>
cooled to 2oC. 6N-HC1 was added dropwise to the reaction mixture, and water and ethyl acetate were added. After<br>
stirring for 30 min, the organic layer was separated. The organic layer was washed with water, aqueous saturated<br>
sodium bicarbonate and aqueous saturated sodium chloride, and dried over sodium sulfate. Filtration and<br>
evaporation gave the crude product, which was purified by silica gel column chromatography (ethyl<br>
acetate/n-hexane) to give (5S)-(4-fluorophenyl)-5-hydroxypentanoic acid methyl ester 0.90 g as colorless oil.<br>
The ee [enantioselectivty ee (%)=[(S)%-(R)%]] of the desired product was determined by HPLC using a chiral<br>
column, [column : CHIRALPAKAD (DAICELh mobile phase : ethanol/n-hexane=l/20(v/v)x detection '• UV<br>
at 258 nm]. The result is shown in Table 2.<br><br>
As shown in Table 2, when (R)-2-[bis(4-methoxyphenyl)hydroxymethyl]pyrrolidine was used as a catalyst at large<br>
scale production, the ee was larger than usual (R)-2-<br><br>
(diphenylhydroxymethyl)pyrrolidine.<br>
[Example 4]<br>
Preparation of (4S)-(4-ben2yloxyphenyl)-1-(4-fluorophenyl)-(3R)-[(3S)-(4-fluorophenyl)-3-<br>
hydroxypropyl]azetidin-2-one<br>
Chlorotrimethylsilane (0.33 mL, 0.02613 mol) was added to a suspension of sodium borohydride (0.099 g,<br>
0.02613 mol) in tetrahydrofuran (15.1 mL) at 19oC, and the reaction mixture was stirred under reflux for 1 hr. The<br>
reaction mixture was cooled to 22oC, and , a solution of (R)-2-<br>
[bis(4-methoxyphenyl)hydroxymethyl]pyrro]idine (0.063 g, 0.000201 mol) in tetrahydrofuran (5.2 mL) was added.<br>
After stirring for 0.5 hr, a solution of (4S)-(4-benzyloxyphenyl)-l -(4-<br>
fluorophenyl)-(3R)-[3-(4-fluorophenyl)-3-oxopropyl]azetidin-2-one (l.00g, 0.00201 mol) in tetrahydrofuran (5.2<br>
mL) was added dropwise during 8 min. After stirring for 1 hr, the reaction mixture was cooled to 2oC. 6N-HC1<br>
was added dropwise to the reaction mixture, and water and toluene were added. After stirring for 30 min, the<br>
organic layer was separated. The organic layer was washed with water, aqueous saturated sodium bicarbonate and<br>
aqueous saturated sodium chloride, and dried over sodium sulfate. Filtration and evaporation gave the crude<br>
product, which was purified by silica gel column chromatography (ethyl acetate/n-hexane)<br>
(4SH4-benzyloxyphenyl)-1-(4-fluorophenyl)-(3R)-[(3S)-(4-fluorophenyl)-3-<br>
hydroxypropyl]azetidin-2-one 0.89 g as colorless crystals.<br>
1H-NMR(CDCl3)δ= 1.88-2.01 (m, 4H), 2.19 (d, J=4Hz, 1H), 3.07 (dt, J=2Hz, 8Hz, 1H), 4.57 (d, J=2Hz, 1H),<br>
4.71-4.73 (m, 1H), 5.29 (s, 2H), 6.90-7.03 (m, 6H), 7.21-7.43 (m, 11H).<br>
The ee [enantioselectivty ee (%)=[(S)%-(R)%]] of the desired product was determined by HPLC using a chiral<br>
column, [column : CHIRALPAKAD (DAICEL), mobile phase : ethanol/n-hexane= 1/9 (v/v), detection : UV<br>
at 258 ran]. The result is shown in Table 3.<br>
[Comparative Example 2]<br>
Chlorotrimethylsilane (0.33 mL, 0.02613 mol) was added to a suspension of sodium borohydride (0.099 g,<br>
0.02613 mol) in tetrahydrofuran (15.1 mL) at 19oC, and the reaction mixture was stirred under reflux for 1 hr. The<br>
reaction mixture was cooled to 22t, and a solution of 2-<br>
(diphenylhydroxymethyl)pyrrolidine (0.051 g, 0.000201 mol) in tetrahydrofuran (5.2 mL) was added. After stirring<br>
for 0.5 hr, a solution of (4S)-(4-benzyloxyphenyl)-1-(4- fluorophenyl)-(3R)- [3-(4-<br>
fluorophenyl)-3-oxopropyl]azetidin-2-on (l.00g, 0.00201 mol) in tetrahydrofuran (5.2 mL) was added dropwise<br>
during 7 min. After stirring for 70 min, the reaction mixture was cooled to 2°C. 6N-HC1 was added dropwise to<br>
the reaction mixture, and water and toluene were added. After stirring for 30 min, the organic layer was separated.<br>
The organic layer was washed with water, aqueous saturated sodium bicarbonate and aqueous saturated sodium<br>
chloride, and dried over sodium sulfate. Filtration and evaporation gave the crude product, which was purified by<br>
silica	gel	column	chromatography	(ethyl	acetate/n-hexane)<br>
(4S)-(4-benzyloxyphenyl)-l -(4-fluorophenyl)-(3R)-[(3S)-<br>
(4-fluorophenyl)-3-hydroxypropyl]azetidin-2-one 0.92 g as colorless crystals.<br>
1H-NMR(CDCl3)δ= 1.88-2.01 (m, 4H), 2.19 (d, J=4Hz, 1H), 3.07 (dt, J=2Hz, 8Hz, 1H), 4.57 (d, J=2Hz, 1H),<br>
4.71-4.73 (m, 1H), 5.29 (s, 2H), 6.90-7.03 (m, 6H), 7.21-7.43 (m, 11H).<br>
The ee of the desired product was determined by HPLC using a chiral column, [column : CHIRALPAK AD<br>
(DAICEL, mobile phase : ethanol/n-hexane=1/9(v/v), detection : UV at 258 nm].<br><br>
The result is shown in Table 3.<br><br>
As shown in Table 3, when (R)-2-[bis(4-niethoxyphenyl)hydroxymethyl]pyrrolidine was used as a catalyst at the<br>
same scale production, the ee was larger about 2-fold than usual (R)-2-<br>
(diphenylhydroxymethyl)pyrrolidine.<br>
FIELD OF INDUSTRIAL APPLICATION<br>
Aromatic ketones are reduced to optically active alcohols in high enantioselectivity by using of the reduction<br>
process in this invention at large scale production. This invention is useful for producing optically active alcohols<br>
such as ezetimibe: ([l-(4-fluorophenyl)-(3R)-[3-(4-fluorophenyl)-(3S)-<br>
hydroxypropyl]-(4S)-{4-hydroxyphenyl)azetidin-2-one]), which is useful as hypochlesterolemic agents in the<br>
prevention and treatment of atherosclerosis. The advantage of this process is that<br>
(R)-2-[bis(4-methoxyphenyl)hydroxymethyl]pylTolidine is recovered in high yleld at reaction end-point by simple<br>
operation such as extraction, and recyclable after purification such as recrystallization. Furthermore, this reaction<br>
proceeds at room temperature, and is not required low reaction temperature.<br><br>
We Claim:<br>
1.	A process for preparing an optically active alcohol represented by formula (V):<br><br>
wherein, R1 are selected from hydrogen atom, halogen atom, lower alkyl group (1 to 5 carbon atom), lower<br>
haloalkyl group (1 to 5 carbon atom), lower alkoxycarbonyl group (1 to 5 carbon atom), lower alkoxy group (1 to<br>
5 carbon atom), hydroxyl group, nitro group, cyano group, lower acyloxy group (1 to 5 carbon atom), lower<br>
alkylthio group (1 to 5 carbon atom), lower alkylsulfonyl group (1 to 5 carbon atom), substituted and<br>
unsubstituted amino group, substituted and unsubstituted carbamoyl group, substituted and unsubstituted aromatic<br>
ring or heterocycle, and<br>
R2 is -(CH2)n-R3 wherein, n is 1 to 5 integer. R3 are selected from hydrogen atom, halogen atom, lower<br>
alkoxycarbonyl group (1 to 5 carbon atom), lower alkoxy group (1 to 5 carbon atom), lower alkylthio group (1 to<br>
5 carbon atom), lower alkylsulfonyl group (1 to 5 carbon atom), substituted and unsubstituted amino group,<br>
unsubstituted carbamoyl group, substituted and unsubstituted aromatic ring or heteroaromatic ring and formula<br>
(II):<br><br>
{wherein, R4 are lower alkyl group (1 to 5 carbon atom), substituted and unsubstituted aromatic<br>
ring, and substituted and unsubstituted benzyl group.}<br>
and formula (III):<br><br>
{wherein, R5 and R6 are the same or different and are selected from hydrogen atom, halogen atom, lower alkyl<br>
group (1 to 5 carbon atom), lower haloalkyl group (1 to 5 carbon atom), lower alkoxycarbonyl group (1 to 5<br>
carbon atom), lower alkoxy group (1 to 5 carbon atom), lower acyloxy group (1 to 5 carbon atom), hydroxyl<br>
group, nitro group, cyano group, substituted and unsubstituted benzyloxy group, substituted silyloxy group, lower<br>
alkylthio group (1 to 5 carbon atom), lower alkylsulfonyl group (1 to 5 carbon atom), substituted and<br>
unsubstituted amino group, substituted and unsubstituted carbamoyl group, substituted and unsubstituted aromatic<br>
ring or heteroaromatic ring, substituted and unsubstituted tetrahydropyranyl group, lower alkyl group containing<br><br>
substituted and unsubstituted tetrahydropyranyl group (1 to 5 carbon atom), lower alkyl group containing amino<br>
group (1 to 5 carbon atom)},<br>
which comprises: reducing aromatic ketones represented by formula (I):<br><br>
wherein R1 and R2 are as defined above,<br>
with sodium borohydride, chlorotrimethylsilane and optically active 2-[bis(4-<br>
methoxyphenyl)hydroxymethyl]pyrrolidine represented by formula (IV):<br><br>
to give optically active alcohol represented by formula (V).<br>
2.	A process for stereoselectively preparing 3-[(5S)-(4-fluorophenyl)-5-hydroxypentanoyl]-(4S)-phenyl-<br>
l,3-oxazolidin-2-one represented by formula (VII):<br><br>
which comprises: reducing 3-[5-(4-fluorophenyl)-5-oxopentanoyl]-(4S)-phenyl-1,3-oxazolidin-2-one<br>
represented by formula (VI):<br><br>
with sodium borohydride, chlorotrimethylsilane and optically active (R)-2-[bis(4-<br>
methoxyphenyl)hydroxymethyl]pyrrolidine represented by formula (IV):<br><br>
to give 3-[(5S)-(4-fluorophenyl)-5-hydroxypentanoyl]-(4S)-phenyl-1,3-oxazolidin-2-one.<br><br>
3.	A process for preparing (5S)-(4-fluorophenyl)-5-oxopentanoic acid methyl ester represented by formula<br>
(IX):<br><br>
which comprises: reducing 5-(4-fluarophenyl)-5-oxopentanoic acid methyl ester represented by formula<br>
(VIII):<br><br>
with sodium borohydride, chlorotrimethylsilane and optically active (R)-2-[bis(4-<br>
methoxyphenyl)hydroxymethyl]pyrrolidine represented by formula (IV)<br><br>
to give (5S)-(4-fluorophenyl)-5-oxopentanoic acid methyl ester.<br>
4.	A process for preparing (4S)-(4-benzyloxyphenyl)-1-(4-fluorophenyl)-(3R)-[(3S)-(4-fluorophenyl)-<br>
(3S)-3-hydoxypropyl]azetidin-2-one represented by formula (XI):<br><br>
which comprises: reducing (4S)-(4-benzyloxyphenyl)-1-(4-fluorophenyl)-(3R)-[3-(4- fluorophenyl)-3-<br>
oxopropyl]azetidin-2-one represented by formula (X)<br><br>
with sodium borohydride, chlorotrimethylsilane and optically active (R)-2-[bis(4-<br><br>
methoxyphenyl)hydroxymethyl]pyrrolidine represented by formula (IV)<br><br>
to give (4S)-(4-benzyloxyphenyl)-1-(4-fluorophenyl)-(3R)-[(3S)-(4-fluorophenyl)- (3S)-3-hydoxypropyl]azetidin-<br>
2-one.<br><br><br><br>
ABSTRACT<br><br><br>
METHOD OF PRODUCING OPTICALLY ACTIVE ALCOHOL<br>
This invention relates to a process for preparing an optically active alcohol represented by formula (V):<br><br>
wherein, R1 and R2 are as described in the specification, which comprises: reducing aromatic ketones<br>
represented by formula (I):<br><br>
wherein R1 and R2 are as described in the specification, with sodium borohydride, chlorotrimethylsilane<br>
and optically active 2-[bis(4-methoxyphenyl)hydroxymethyl]pyrrolidine represented by formula (IV):<br><br>
to give optically active alcohol represented by formula (V).</td>
			</tr>
		</table>	
		<br>
		<h3>Documents:</h3>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MzM2My1LT0xOUC0yMDA4LSgxNi0xMC0yMDEyKS1DT1JSRVNQT05ERU5DRS5wZGY=" target="_blank" style="word-wrap:break-word;">3363-KOLNP-2008-(16-10-2012)-CORRESPONDENCE.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MzM2My1LT0xOUC0yMDA4LSgxNi0xMC0yMDEyKS1PVEhFUlMucGRm" target="_blank" style="word-wrap:break-word;">3363-KOLNP-2008-(16-10-2012)-OTHERS.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MzM2My1LT0xOUC0yMDA4LSgyOS0xMC0yMDEyKS1BQlNUUkFDVC5wZGY=" target="_blank" style="word-wrap:break-word;">3363-KOLNP-2008-(29-10-2012)-ABSTRACT.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MzM2My1LT0xOUC0yMDA4LSgyOS0xMC0yMDEyKS1BTk5FWFVSRSBUTyBGT1JNIDMucGRm" target="_blank" style="word-wrap:break-word;">3363-KOLNP-2008-(29-10-2012)-ANNEXURE TO FORM 3.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MzM2My1LT0xOUC0yMDA4LSgyOS0xMC0yMDEyKS1DTEFJTVMucGRm" target="_blank" style="word-wrap:break-word;">3363-KOLNP-2008-(29-10-2012)-CLAIMS.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MzM2My1LT0xOUC0yMDA4LSgyOS0xMC0yMDEyKS1DT1JSRVNQT05ERU5DRS5wZGY=" target="_blank" style="word-wrap:break-word;">3363-KOLNP-2008-(29-10-2012)-CORRESPONDENCE.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MzM2My1LT0xOUC0yMDA4LSgyOS0xMC0yMDEyKS1ERVNDUklQVElPTiAoQ09NUExFVEUpLnBkZg==" target="_blank" style="word-wrap:break-word;">3363-KOLNP-2008-(29-10-2012)-DESCRIPTION (COMPLETE).pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MzM2My1LT0xOUC0yMDA4LSgyOS0xMC0yMDEyKS1GT1JNLTEucGRm" target="_blank" style="word-wrap:break-word;">3363-KOLNP-2008-(29-10-2012)-FORM-1.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MzM2My1LT0xOUC0yMDA4LSgyOS0xMC0yMDEyKS1GT1JNLTIucGRm" target="_blank" style="word-wrap:break-word;">3363-KOLNP-2008-(29-10-2012)-FORM-2.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MzM2My1LT0xOUC0yMDA4LSgyOS0xMC0yMDEyKS1GT1JNLTMucGRm" target="_blank" style="word-wrap:break-word;">3363-KOLNP-2008-(29-10-2012)-FORM-3.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MzM2My1LT0xOUC0yMDA4LSgyOS0xMC0yMDEyKS1GT1JNLTUucGRm" target="_blank" style="word-wrap:break-word;">3363-KOLNP-2008-(29-10-2012)-FORM-5.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MzM2My1LT0xOUC0yMDA4LSgyOS0xMC0yMDEyKS1PVEhFUlMucGRm" target="_blank" style="word-wrap:break-word;">3363-KOLNP-2008-(29-10-2012)-OTHERS.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MzM2My1LT0xOUC0yMDA4LSgyOS0xMC0yMDEyKS1QRVRJVElPTiBVTkRFUiBSVUxFIDEzNy5wZGY=" target="_blank" style="word-wrap:break-word;">3363-KOLNP-2008-(29-10-2012)-PETITION UNDER RULE 137.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MzM2My1rb2xucC0yMDA4LWFic3RyYWN0LnBkZg==" target="_blank" style="word-wrap:break-word;">3363-kolnp-2008-abstract.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MzM2My1LT0xOUC0yMDA4LUFTU0lHTk1FTlQgMS4xLnBkZg==" target="_blank" style="word-wrap:break-word;">3363-KOLNP-2008-ASSIGNMENT 1.1.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MzM2My1rb2xucC0yMDA4LWFzc2lnbm1lbnQucGRm" target="_blank" style="word-wrap:break-word;">3363-kolnp-2008-assignment.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MzM2My1LT0xOUC0yMDA4LUNBTkNFTExFRCBQQUdFUy5wZGY=" target="_blank" style="word-wrap:break-word;">3363-KOLNP-2008-CANCELLED PAGES.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MzM2My1rb2xucC0yMDA4LWNsYWltcy5wZGY=" target="_blank" style="word-wrap:break-word;">3363-kolnp-2008-claims.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MzM2My1LT0xOUC0yMDA4LUNPUlJFU1BPTkRFTkNFIDEuMS5wZGY=" target="_blank" style="word-wrap:break-word;">3363-KOLNP-2008-CORRESPONDENCE 1.1.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MzM2My1rb2xucC0yMDA4LWNvcnJlc3BvbmRlbmNlLnBkZg==" target="_blank" style="word-wrap:break-word;">3363-kolnp-2008-correspondence.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MzM2My1rb2xucC0yMDA4LWRlc2NyaXB0aW9uIChjb21wbGV0ZSkucGRm" target="_blank" style="word-wrap:break-word;">3363-kolnp-2008-description (complete).pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MzM2My1LT0xOUC0yMDA4LUVYQU1JTkFUSU9OIFJFUE9SVC5wZGY=" target="_blank" style="word-wrap:break-word;">3363-KOLNP-2008-EXAMINATION REPORT.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MzM2My1rb2xucC0yMDA4LWZvcm0gMS5wZGY=" target="_blank" style="word-wrap:break-word;">3363-kolnp-2008-form 1.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MzM2My1rb2xucC0yMDA4LWZvcm0gMTgucGRm" target="_blank" style="word-wrap:break-word;">3363-kolnp-2008-form 18.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MzM2My1rb2xucC0yMDA4LWZvcm0gMy5wZGY=" target="_blank" style="word-wrap:break-word;">3363-kolnp-2008-form 3.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MzM2My1rb2xucC0yMDA4LWZvcm0gNS5wZGY=" target="_blank" style="word-wrap:break-word;">3363-kolnp-2008-form 5.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MzM2My1LT0xOUC0yMDA4LUdQQSAxLjEucGRm" target="_blank" style="word-wrap:break-word;">3363-KOLNP-2008-GPA 1.1.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MzM2My1rb2xucC0yMDA4LWdwYS5wZGY=" target="_blank" style="word-wrap:break-word;">3363-kolnp-2008-gpa.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MzM2My1LT0xOUC0yMDA4LUdSQU5URUQtQUJTVFJBQ1QucGRm" target="_blank" style="word-wrap:break-word;">3363-KOLNP-2008-GRANTED-ABSTRACT.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MzM2My1LT0xOUC0yMDA4LUdSQU5URUQtQ0xBSU1TLnBkZg==" target="_blank" style="word-wrap:break-word;">3363-KOLNP-2008-GRANTED-CLAIMS.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MzM2My1LT0xOUC0yMDA4LUdSQU5URUQtREVTQ1JJUFRJT04gKENPTVBMRVRFKS5wZGY=" target="_blank" style="word-wrap:break-word;">3363-KOLNP-2008-GRANTED-DESCRIPTION (COMPLETE).pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MzM2My1LT0xOUC0yMDA4LUdSQU5URUQtRk9STSAxLnBkZg==" target="_blank" style="word-wrap:break-word;">3363-KOLNP-2008-GRANTED-FORM 1.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MzM2My1LT0xOUC0yMDA4LUdSQU5URUQtRk9STSAyLnBkZg==" target="_blank" style="word-wrap:break-word;">3363-KOLNP-2008-GRANTED-FORM 2.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MzM2My1LT0xOUC0yMDA4LUdSQU5URUQtRk9STSAzLnBkZg==" target="_blank" style="word-wrap:break-word;">3363-KOLNP-2008-GRANTED-FORM 3.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MzM2My1LT0xOUC0yMDA4LUdSQU5URUQtRk9STSA1LnBkZg==" target="_blank" style="word-wrap:break-word;">3363-KOLNP-2008-GRANTED-FORM 5.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MzM2My1LT0xOUC0yMDA4LUdSQU5URUQtU1BFQ0lGSUNBVElPTi1DT01QTEVURS5wZGY=" target="_blank" style="word-wrap:break-word;">3363-KOLNP-2008-GRANTED-SPECIFICATION-COMPLETE.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MzM2My1LT0xOUC0yMDA4LUlOVEVSTkFUSU9OQUwgUFVCTElDQVRJT04gMS4xLnBkZg==" target="_blank" style="word-wrap:break-word;">3363-KOLNP-2008-INTERNATIONAL PUBLICATION 1.1.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MzM2My1rb2xucC0yMDA4LWludGVybmF0aW9uYWwgcHVibGljYXRpb24ucGRm" target="_blank" style="word-wrap:break-word;">3363-kolnp-2008-international publication.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MzM2My1LT0xOUC0yMDA4LUlOVEVSTkFUSU9OQUwgU0VBUkNIIFJFUE9SVCAmIE9USEVSUy5wZGY=" target="_blank" style="word-wrap:break-word;">3363-KOLNP-2008-INTERNATIONAL SEARCH REPORT &amp; OTHERS.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MzM2My1rb2xucC0yMDA4LWludGVybmF0aW9uYWwgc2VhcmNoIHJlcG9ydC5wZGY=" target="_blank" style="word-wrap:break-word;">3363-kolnp-2008-international search report.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MzM2My1LT0xOUC0yMDA4LU9USEVSUy5wZGY=" target="_blank" style="word-wrap:break-word;">3363-KOLNP-2008-OTHERS.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MzM2My1rb2xucC0yMDA4LXBjdCBwcmlvcml0eSBkb2N1bWVudCBub3RpZmljYXRpb24ucGRm" target="_blank" style="word-wrap:break-word;">3363-kolnp-2008-pct priority document notification.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MzM2My1rb2xucC0yMDA4LXBjdCByZXF1ZXN0IGZvcm0ucGRm" target="_blank" style="word-wrap:break-word;">3363-kolnp-2008-pct request form.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MzM2My1LT0xOUC0yMDA4LVBFVElUSU9OIFVOREVSIFJVTEUgMTM3LnBkZg==" target="_blank" style="word-wrap:break-word;">3363-KOLNP-2008-PETITION UNDER RULE 137.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MzM2My1LT0xOUC0yMDA4LVJFUExZIFRPIEVYQU1JTkFUSU9OIFJFUE9SVC5wZGY=" target="_blank" style="word-wrap:break-word;">3363-KOLNP-2008-REPLY TO EXAMINATION REPORT.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MzM2My1rb2xucC0yMDA4LXNwZWNpZmljYXRpb24ucGRm" target="_blank" style="word-wrap:break-word;">3363-kolnp-2008-specification.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MzM2My1LT0xOUC0yMDA4LVRSQU5TTEFURUQgQ09QWSBPRiBQUklPUklUWSBET0NVTUVOVC5wZGY=" target="_blank" style="word-wrap:break-word;">3363-KOLNP-2008-TRANSLATED COPY OF PRIORITY DOCUMENT.pdf</a></p>
		<br>
		<div class="pull-left">
			<a href="256183-b-crystalline-polypropylenes.html">&laquo; Previous Patent</a>
		</div>
		<div class="pull-right">
			<a href="256185-nutrition-containing-fat-blend.html">Next Patent &raquo;</a>
		</div>			
	</div><!-- /span8 -->
	<div class="span4">
		<div class="well infobox">
			<table class="table table-condensed">
				<tr>
					<th>Patent Number</th>
					<td>256184</td>
				</tr>
				<tr>
					<th>Indian Patent Application Number</th>
					<td>3363/KOLNP/2008</td>
				</tr>
				<tr>
					<th>PG Journal Number</th>
					<td>20/2013</td>
				</tr>
				<tr>
					<th>Publication Date</th>
					<td>17-May-2013</td>
				</tr>
				<tr>
					<th>Grant Date</th>
					<td>13-May-2013</td>
				</tr>
				<tr>
					<th>Date of Filing</th>
					<td>18-Aug-2008</td>
				</tr>
				<tr>
					<th>Name of Patentee</th>
					<td>KOTOBUKI PHARMACEUTICAL CO., LTD.</td>
				</tr>
				<tr>
					<th>Applicant Address</th>
					<td>6351 OAZA-SAKAKI, SAKAKI-MACHI HANISHINA-GUN, NAGANO</td>
				</tr>
				<tr>
					<td colspan=2>
								<h5>Inventors:</h5>
								<table class="table">
									<tr>
										<th>#</th>
										<th>Inventor's Name</th>
										<th>Inventor's Address</th>
									</tr>

										<tr>
											<td>1</td>
											<td>YOKOTA, MASAYUKI</td>
											<td>2671-10, YAWATA, CHIKUMA-SHI, NAGANO 387-0023</td>
										</tr>
										<tr>
											<td>2</td>
											<td>TOMIYAMA, HIROSHI</td>
											<td>1113, OAZA-SAKAKI, SAKAKI-MACHI, HANISHINA-GUN, NAGANO 389-0601</td>
										</tr>
								</table>
					</td>
				</tr>
				<tr>
					<th>PCT International Classification Number</th>
					<td>C07C 29/143</td>
				</tr>
				<tr>
					<th>PCT International Application Number</th>
					<td>PCT/JP2007/052900</td>
				</tr>
				<tr>
					<th>PCT International Filing date</th>
					<td>2007-02-13</td>
				</tr>
				<tr>
					<td colspan=2>
						<h5>PCT Conventions:</h5>
						<table class="table">
							<tr>
								<th>#</th>
								<th>PCT Application Number</th>
								<th>Date of Convention</th>
								<th>Priority Country</th>
							</tr>

								<tr>
									<td>1</td>
									<td>2006-038964</td>
									<td>2006-02-16</td>
								    <td>Japan</td>
								</tr>

						</table>
					</td>
				</tr>
			</table>
		</div><!-- /well -->
	</div><!-- /span4 -->
</div><!-- /row-fluid -->

        </div>

      </div><!--/row-->

      <footer class="footer">

        <style>
        .allindianpatents-footer { width: 320px; height: 50px; }
        @media(min-width: 500px) { .allindianpatents-footer { width: 468px; height: 60px; } }
        @media(min-width: 800px) { .allindianpatents-footer { width: 728px; height: 90px; } }
        </style>
        <center>
        </center>

        <p>&copy; All Indian Patents, 2013-2021.</p>
        <p>Patent data available in the public domain from Indian Patents Office, Department of Industrial Policy and Promotions, Ministry of Commerce and Industry, Government of India.</p>
      </footer>

    </div> <!-- /container -->

    <!-- Javascripts
    ================================================== -->
    <!-- Placed at the end of the document so the pages load faster -->
    <script src="../assets/application-95f297ff0d8d2015987f04b30593c800.js" type="text/javascript"></script>

    <!-- Start of StatCounter Code for Default Guide -->
    <script type="text/javascript">
    var sc_project=8902313; 
    var sc_invisible=1; 
    var sc_security="3c1f8147"; 
    var scJsHost = (("https:" == document.location.protocol) ?
    "https://secure." : "http://www.");
    document.write("<sc"+"ript type='text/javascript' src='" +
    scJsHost+
    "statcounter.com/counter/counter.js'></"+"script>");
    </script>
    <noscript><div class="statcounter"><a title="web stats"
    href="http://statcounter.com/free-web-stats/"
    target="_blank"><img class="statcounter"
    src="http://c.statcounter.com/8902313/0/3c1f8147/1/"
    alt="web stats"></a></div></noscript>
    <!-- End of StatCounter Code for Default Guide -->

    <script>
      (function(i,s,o,g,r,a,m){i['GoogleAnalyticsObject']=r;i[r]=i[r]||function(){
      (i[r].q=i[r].q||[]).push(arguments)},i[r].l=1*new Date();a=s.createElement(o),
      m=s.getElementsByTagName(o)[0];a.async=1;a.src=g;m.parentNode.insertBefore(a,m)
      })(window,document,'script','http://www.google-analytics.com/analytics.js','ga');

      ga('create', 'UA-244143-31', 'allindianpatents.com');
      ga('send', 'pageview');

    </script>

  </body>

<!-- Mirrored from www.allindianpatents.com/patents/256184-method-of-producing-optically-active-alcohol by HTTrack Website Copier/3.x [XR&CO'2014], Fri, 05 Apr 2024 09:49:58 GMT -->
</html>
